Loading...
Loading...
India's omeprazole imports from UNITED KINGDOM total $72.9K across 37 shipments from 15 foreign suppliers. E-PHARM LIMITED leads with $23.2K in import value; the top 5 suppliers together control 85.8% of this origin. Leading Indian buyers include DR.REDDY'S LABORATORIES LTD. This corridor reflects India's pharmaceutical import demand for omeprazole — a diversified sourcing base with multiple active suppliers from UNITED KINGDOM.

E-PHARM LIMITED is the leading Omeprazole supplier from UNITED KINGDOM to India, with import value of $23.2K across 16 shipments. The top 5 suppliers — E-PHARM LIMITED, PHARMA MODUS LIMITED, ACCORD-UK LIMITED, E PHARM LIMITED, PHARMAQUELLE LLC C/O NOBLE HEALTHCARE LTD — collectively account for 85.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | E-PHARM LIMITED | $23.2K | 16 | 31.8% |
| 2 | PHARMA MODUS LIMITED | $17.0K | 3 | 23.4% |
| 3 | ACCORD-UK LIMITED | $12.6K | 1 | 17.3% |
| 4 | E PHARM LIMITED | $5.4K | 3 | 7.4% |
| 5 | PHARMAQUELLE LLC C/O NOBLE HEALTHCARE LTD | $4.3K | 1 | 6.0% |
| 6 | PHARMAQUELLE LLC C O NOBLE HEALTHCARE LIMITED | $2.8K | 1 | 3.9% |
| 7 | ESPEE PHARMA UK LTD | $1.7K | 1 | 2.4% |
| 8 | NEWLIFE BIOPHARMA LIMTED | $1.7K | 1 | 2.3% |
| 9 | WAYMADE PLC | $982 | 2 | 1.3% |
| 10 | ACCORD-UK LTD | $928 | 2 | 1.3% |
| 11 | E-PHARMA LIMITED | $838 | 1 | 1.1% |
| 12 | CUBIC PHARMACEUTICALS LTD | $579 | 1 | 0.8% |
| 13 | LM MANUFACTURING LIMITED | $441 | 2 | 0.6% |
| 14 | CP PHARMACEUTICALS LIMITED | $273 | 1 | 0.4% |
| 15 | SMARTWAY PHARMACEUTICALS LIMITED | $6 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $17.7K | 12 | 24.3% |
| 2 | AUROBINDO PHARMA LTD | $16.1K | 1 | 22.1% |
| 3 | INTAS PHARMACEUTICALS LIMITED | $13.6K | 3 | 18.6% |
| 4 | MICRO LABS LIMITED | $7.2K | 2 | 9.9% |
| 5 | GRANULES INDIA LIMITED | $4.6K | 2 | 6.3% |
| 6 | EMCURE PHARMACEUTICALS LIMITED | $4.0K | 2 | 5.4% |
| 7 | TORRENT PHARMACEUTICALS LTD | $2.3K | 2 | 3.1% |
| 8 | VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED | $1.7K | 1 | 2.4% |
| 9 | APOTHECON PHARMACEUTICALS PRIVATE LIMITED | $982 | 2 | 1.3% |
| 10 | AUROBINDO PHARMA LIMITED | $935 | 2 | 1.3% |
| 11 | VEEDA CLINICAL RESEARCH LIMITED | $883 | 1 | 1.2% |
| 12 | MEDREICH LIMITED | $838 | 1 | 1.1% |
| 13 | MSN LABORATORIES PRIVATE LIMITED | $805 | 1 | 1.1% |
| 14 | DR.REDDY'S LABORATORIES LIMITED | $618 | 1 | 0.8% |
| 15 | AUXILLA PHARMACEUTICALS AND RESEARCH LLP | $441 | 2 | 0.6% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Omeprazole suppliers from UNITED KINGDOM to India include E-PHARM LIMITED, PHARMA MODUS LIMITED, ACCORD-UK LIMITED. The leading supplier is E-PHARM LIMITED with import value of $23.2K USD across 16 shipments. India imported Omeprazole worth $72.9K USD from UNITED KINGDOM in total across 37 shipments.
India imported Omeprazole worth $72.9K USD from UNITED KINGDOM across 37 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Omeprazole sourced from UNITED KINGDOM include DR.REDDY'S LABORATORIES LTD, AUROBINDO PHARMA LTD, INTAS PHARMACEUTICALS LIMITED. The largest buyer is DR.REDDY'S LABORATORIES LTD with $17.7K in imports across 12 shipments.
The total value of Omeprazole imports from UNITED KINGDOM to India is $72.9K USD, across 37 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
37 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists